Focused ultrasound ablation · UK
HIFU — high intensity focused ultrasound, non-invasive focal treatment for localised prostate cancer and other tissues.
HIFU delivers focused ultrasound energy that heats and ablates tissue with sub-millimetre precision, without incisions. Primary and emerging modern indications: localised prostate cancer (focal or whole-gland), uterine fibroids and select liver / bone lesions.
Key facts about HIFU
- 01
Focused ultrasound ablation
High-frequency focused ultrasound heats and ablates tissue with sub-millimetre precision — no incisions, no ionising radiation.
- 02
NICE IPG-approved
Approved by NICE Interventional Procedures Guidance for localised prostate cancer, as focal or whole-gland treatment.
- 03
Same-day procedure
Performed under spinal or general anaesthesia, typically as a day case with a catheter on discharge.
- 04
MRI or US-guided
Delivered with MRI or ultrasound guidance — the target is planned to the millimetre before energy is delivered.
- 05
Function-preserving
For focal disease, HIFU preserves urinary and sexual function better than whole-gland radical prostatectomy or radiotherapy.
- 06
Modern MDT-led pathway
Every case is discussed at a urology MDT — HIFU sits alongside surveillance, surgery and radiotherapy as one option, not a stand-alone product.
Where HIFU fits
One option in an MDT-led pathway, not a stand-alone product.
For selected patients with localised, MRI-visible disease, HIFU can treat the tumour and preserve function. It sits alongside surveillance, radical surgery, radiotherapy and brachytherapy — the MDT chooses.
-
Localised, MRI-visible tumour?
Focal HIFU may treat the index lesion while preserving continence and erectile function.
-
Whole-gland disease?
Whole-gland HIFU can be discussed alongside prostatectomy and radiotherapy.
-
Symptomatic fibroids?
MR-guided focused ultrasound (MRgFUS) may be an option for suitable fibroids.
The pathway
From MDT review to treatment day — what happens, in order.
Every HIFU pathway runs the same seven steps, in the same order.
Phase 1 · Before treatment
MDT, imaging, planning
Phase 2 · Treatment day
Day case, anaesthesia, ablation
Phase 3 · After
Catheter, PSA + MRI
- 01
Before
Urology / MDT consultation
Consultant urologist review with the multidisciplinary team — HIFU is only offered when the disease profile fits the evidence.
- 02
Before
MRI prostate + biopsy staging
Multiparametric MRI and targeted biopsy confirm tumour location, grade and volume — the map HIFU planning relies on.
- 03
Before
Pre-op assessment
Anaesthetic review, bloods, ECG and medication review — the standard day-case work-up.
- 04
Treatment day
Fast 6 hours
Nil by mouth from six hours before the procedure. Water up to two hours if permitted by the anaesthetist.
- 05
Treatment day
Spinal or general anaesthesia
Anaesthesia is chosen by the anaesthetist based on your history and the planned duration.
- 06
Treatment day
Transrectal HIFU probe
A transrectal probe delivers focused ultrasound under MRI or ultrasound guidance — the procedure typically takes one to three hours.
- 07
After
Same-day discharge with catheter
Most patients go home the same day with a urinary catheter for around 7–14 days, and a structured PSA + MRI follow-up plan.
What HIFU does
When HIFU is — and isn’t — the right treatment.
HIFU answers a specific question: can we ablate this target without cutting, and preserve function around it. These are the scenarios where it fits.
-
Focal HIFU for localised prostate cancer
Targeted ablation of an index lesion — treating the tumour, not the whole gland.
-
Whole-gland HIFU
Whole-gland ablation as a radical option in selected localised disease.
-
MRI treatment planning
Multiparametric MRI defines the ablation zone with millimetre precision.
-
Continence-preserving approach
Sphincter-sparing planning aims to preserve urinary continence.
-
Erectile-function preservation
For focal treatment, neurovascular-bundle sparing supports erectile function.
-
MRgFUS for uterine fibroids
MR-guided focused ultrasound as a non-invasive alternative for symptomatic fibroids.
-
Repeat treatment if recurrence
HIFU can be repeated in selected patients with in-field recurrence.
-
Red flag: locally advanced disease with capsular breach — HIFU not appropriate, MDT review
Extra-prostatic extension or nodal disease removes HIFU from the pathway — the MDT will steer toward radical surgery, radiotherapy or systemic therapy.
Treatment options and next steps
HIFU is one of eight routes the MDT weighs up.
What each option on the MDT’s list is actually for.
-
Active surveillance
For low-risk, low-volume disease — structured PSA, MRI and biopsy monitoring without immediate treatment.
-
Focal HIFU
Targeted ablation of the index lesion — preserving surrounding tissue and function.
-
Whole-gland HIFU
Ablation of the entire prostate as a radical option in selected patients.
-
Radical prostatectomy
Surgical removal of the prostate — usually robot-assisted — with curative intent.
-
External-beam radiotherapy
IMRT or SBRT delivered over several sessions — a curative alternative to surgery.
-
Brachytherapy
Low- or high-dose-rate seed or catheter brachytherapy for selected localised disease.
-
Post-treatment surveillance
Structured PSA and MRI follow-up to detect recurrence early.
-
MDT review for recurrence
Any recurrence returns to the MDT — salvage HIFU, salvage surgery, radiotherapy or systemic therapy are all on the table.
Our vetted UK network
A small panel of centres, we picked them.
HIFU centres are chosen for MDT integration, HIFU volume and follow-up rigour — not for who is easiest to book.
Selection criteria
How we choose every centre in our network.
-
Consultant urologists and interventional radiologists trained in HIFU
-
MDT-reviewed indication before every procedure
-
Multiparametric MRI planning to a standardised protocol
-
Structured PSA + MRI follow-up with clear salvage pathways
Red flags and what to watch for
When HIFU isn’t the answer — and when to escalate.
HIFU is safe in well-selected patients. The practical points are the situations where HIFU is the wrong tool, and the complications the consent conversation needs to name.
-
Locally advanced prostate cancer
Extra-prostatic extension or nodal spread removes HIFU from the pathway — MDT will steer to radical surgery, radiotherapy or systemic therapy.
-
Post-HIFU recurrence
In-field or out-of-field recurrence is picked up on PSA + MRI surveillance and returned to the MDT for salvage planning.
-
Post-op urinary incontinence
Uncommon after focal HIFU, higher after whole-gland treatment — pelvic-floor rehab is part of the pathway.
-
Post-op erectile dysfunction
Rates are lower than radical prostatectomy but not zero — discussed frankly at consent.
-
Rectal fistula (rare)
A rare complication of transrectal HIFU — reduced by careful planning and modern devices, but part of the consent conversation.
-
Urinary retention post-treatment
A urinary catheter is standard for 7–14 days; a small number of patients need a longer catheter or a repeat trial without.
-
Positive margins requiring salvage
Residual disease at the ablation margin may need repeat HIFU, salvage prostatectomy or radiotherapy.
-
MRI-invisible tumour
HIFU depends on MRI-visible disease. Where the tumour is not MRI-conspicuous, another treatment route is safer.
-
Bulky fibroid with distortion
Very large or heavily distorted fibroids are usually not MRgFUS-suitable — surgical or interventional-radiology options are considered.
Your HIFU report
A HIFU report can look intimidating. It isn’t.
Whatever the finding, the report keeps to the same four parts.
A quiet reminder
The report is written for your doctor, not for you — and that’s normal.
If you would like us to talk you through it before your follow-up, just ask.
- 01 Header
Indication and staging
Your details, the MDT-agreed indication, and the mpMRI + biopsy staging that led to HIFU being offered.
- 02 Technique
Device, guidance and ablation plan
HIFU device used, MRI or ultrasound guidance, ablation zone, energy delivered and any intra-procedural adjustments.
- 03 Findings
Ablation coverage and margins
Coverage of the planned target volume, margin status and any preservation of neurovascular bundles or the external sphincter.
- 04 Impression
The plan — read this first
Catheter plan, follow-up PSA and MRI schedule, and the salvage pathway if surveillance flags recurrence.
Recognised by major UK insurers
Cover depends on your policy and centre; we confirm with your insurer before booking.
Frequently asked
Everything we get asked about HIFU.
Quick answers on NICE approval, focal vs whole-gland, side effects, follow-up, and what happens if HIFU doesn’t work.
-
What is HIFU?
HIFU — high intensity focused ultrasound — uses focused ultrasound waves to heat and ablate tissue with sub-millimetre precision, without incisions or ionising radiation. In modern practice it is used mainly for localised prostate cancer, uterine fibroids and selected liver or bone lesions.
-
Is HIFU approved by NICE?
Yes. NICE Interventional Procedures Guidance supports HIFU for localised prostate cancer, delivered as focal treatment of an index lesion or as whole-gland therapy, within a formal MDT-led pathway.
-
Focal HIFU or whole-gland HIFU — how is the decision made?
The MDT decides. Focal HIFU targets an index lesion and preserves surrounding tissue; whole-gland HIFU treats the entire prostate as a radical option. The choice depends on tumour location, grade, volume and MRI conspicuity.
-
What are the side effects?
The main risks are temporary urinary retention (a catheter is standard for 7–14 days), erectile dysfunction, urinary incontinence — usually milder than radical prostatectomy — and rarely a rectal fistula. Every risk is discussed at consent.
-
How is follow-up organised?
A structured schedule of PSA testing and multiparametric MRI, typically with an early post-treatment MRI and then periodic surveillance. Any recurrence returns to the MDT for salvage planning.
-
Can HIFU treat anything besides prostate cancer?
Yes. MR-guided focused ultrasound (MRgFUS) is used for symptomatic uterine fibroids, and HIFU has emerging roles in selected liver and bone lesions. It is not appropriate for every tumour type — the indication is always MDT-led.
-
What happens if HIFU doesn’t work?
Recurrence is picked up on PSA and MRI surveillance. Options include repeat HIFU in selected cases, salvage prostatectomy, salvage radiotherapy or brachytherapy, and systemic treatment — chosen by the MDT.
Sources
Guidelines this page draws on.
- NICE Interventional Procedures Guidance IPG756 — Focal therapy using high-intensity focused ultrasound for localised prostate cancer.
- European Association of Urology. Guidelines on Prostate Cancer.
- British Association of Urological Surgeons. Patient information and standards.
- UK Focal Therapy Users Group.
Last reviewed 2026-07-30. Next review 2027-07-30. Reviewed by Pulse Atlas Editorial Board, . Approximate reading time 6 minutes.
Related tests
Looking for a different test?
-
Interventional radiology
Image-guided minimally invasive treatments across the body.
Learn more -
Prostate MRI
Multiparametric MRI — the imaging that plans HIFU.
Learn more -
MRI abdomen
Cross-sectional MRI of the abdominal organs.
Learn more -
All tests
Browse every test and procedure we arrange.
Learn more -
Hypertension
Related condition guide.
Learn more -
Type 2 Diabetes
Related condition guide.
Learn more -
Cognitive Behaviour Therapy
Related treatment option.
Learn more -
Complementary Alternative Medicine
Related treatment option.
Learn more
In practice, in London
The London pathway for hifu high intensity focused ultrasound
With hifu high intensity focused ultrasound, the London question is usually about report turnaround and the radiologist reading it — not whether the scan is available. Public provision for hifu high intensity focused ultrasound is competent but constrained by capacity. Private London clinics tend to have shorter diaries and longer appointment slots, so you get the same specialists with more time. For people who’ve been going round in circles with primary care, that first proper conversation is often what shifts things.
The mechanics are straightforward: a consultant appointment, any tests done at a nearby CQC-registered site, and a written report back within a few days. London’s density of private diagnostics — Marylebone, the City, Chelsea, Canary Wharf — means most patients can find something that fits around work without a cross-town trek. For hifu high intensity focused ultrasound specifically, the difference between a routine report and a sub-speciality read is where private care earns its keep.
There are a lot of consultants in London who can technically handle hifu high intensity focused ultrasound. Fewer who do it week in, week out for the exact question you’re bringing. We spend most of our time working out which is which — and being straight when a different test or a different specialist would serve you better. Everything runs to CQC, GMC and Royal College standards; the choice is about fit, not floor.
Nearby in the library